↓ Skip to main content

Omentin as a novel biomarker of metabolic risk factors

Overview of attention for article published in Diabetology & Metabolic Syndrome, July 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
97 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Omentin as a novel biomarker of metabolic risk factors
Published in
Diabetology & Metabolic Syndrome, July 2012
DOI 10.1186/1758-5996-4-37
Pubmed ID
Authors

Rei Shibata, Noriyuki Ouchi, Ryotaro Takahashi, Yuya Terakura, Koji Ohashi, Nobuo Ikeda, Akiko Higuchi, Hiroko Terasaki, Shinji Kihara, Toyoaki Murohara

Abstract

Omentin is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of omentin with the number of metabolic risk factors.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Unknown 55 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 16%
Student > Ph. D. Student 8 14%
Student > Doctoral Student 7 13%
Researcher 6 11%
Student > Master 5 9%
Other 14 25%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 19 34%
Biochemistry, Genetics and Molecular Biology 8 14%
Agricultural and Biological Sciences 5 9%
Chemistry 5 9%
Engineering 4 7%
Other 5 9%
Unknown 10 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2012.
All research outputs
#15,248,503
of 22,673,450 outputs
Outputs from Diabetology & Metabolic Syndrome
#362
of 657 outputs
Outputs of similar age
#104,448
of 164,574 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#11
of 11 outputs
Altmetric has tracked 22,673,450 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 657 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,574 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.